Covishield, locally manufactured by Serum Institute of India and Bharat Biotech's indigenously manufactured Covaxin, both the vaccine manufacturers jointly communicated their pledge towards a 'smooth rollout' of COVID-19 vaccines to India and the world.In a joint statement issued by SII CEO Adar Poonawalla and Bharat Biotech's Chairman Dr Krishna Ella, the companies said that "the more important task in front of them is saving the lives and livelihoods of populations in India and the world."Vaccines are a global public health good and they have the power to save lives and accelerate the return to economic normalcy at the earliest, the companies further stated."Now that two COVID-19 vaccines have been issued EUA (emergency use authorization).